4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Follow Us : Follow On Facebook Follow On Twitter Follow On Youtube
Chikungunya Virus In India
COMPED 2006

Dr. Ashwani Agrawal

Consultant Pediatrician, Raipur

Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus belonging to family Togaviridae. It was isolated for the first time from a Tanzanian outbreak in 1952. CHIKV is an enveloped, positive-stand RNA virus.

EPIDEMIOLOGY

CHIKV is geographically distributed in Africa, India and South-East Asia. In Asia, CHIKV is transmitted from human to human mainly by A. aegypti. Recent reports of large scale outbreaks of fever caused b y chikungunya virus infection in several parts of Southern India have confirmed the re-emergence of this virus. It has been estimated that over 1,80,000 cases have occurred in India since December 2005. According to the National Institute of Virology, Pune, out of 362 found positive for chikungunya, antibodies, six for dengue fever and 15 related to both the fevers.

CLINICAL MANIFESTATION

CHIKV infection can cause a debilitating illness, most often characterized by fever, headache, fatigue, nausea, vomiting, muscle pain, rash, and joint pain. The term 'chikungunya' is Swahili for 'that which bends up'. The incubation period (time from infection to illness) can be 2-12 days, but is usually 3-7 days. "Silent" CHIKV infections (infections without illness) do occur; but how commonly this happens is not yet known.

CHIKV is spread by the bite of an infected mosquito. Mosquitoes become infected when they feed on a person infected with CHIKV. Monkeys, and possibly other wild animals, may also serve as reservoirs of the virus. Aedes aegypti, a household container breeder and aggressive daytime biter which is attracted to humans, is the primary vector of CHIKV to humans.

Acute chikungunya fever typically lasts a few days to a couple of weeks, some patients have prolonged fatigue lasting several weeks. Additionally, some patients have reported incapacitating joint pain, or arthritis which may last for weeks or months. The incidence of chikungunya fever could be much higher than what has been previously reported.

CHIKV infection (whether clinical or silent) is thought to confer life-long immunity.
TREATMENT: No vaccine or specific antiviral treatment for chikungunya fever is available. Treatment is symptomatic; rest, fluids, and ibuprofen, naproxen, acetaminophen, or paracetamol may relieve symptoms of fever and aching. Aspirin should be avoided during the acute stages of the illness.

Infected persons should be protected from further mosquito exposure (staying indoors and/or under a mosquito net during the first few days of illness) so that they can't contribute to the transmission cycle.

PREVENTION

The best way to avoid CHIKV infection is to prevent mosquito bites. There is no vaccine or preventive drug. Prevention tips are similar to those for dengue or West Nile virus:

  • Use insect repellent containing a DEET or another EPA-registered active ingredient on exposed skin. Always follow the directions on the package.
  • Wear long sleeves and pants (ideally treat clothes with permethrin or another repellent).
  • Have secure screens on windows and doors to keep mosquitoes out.
  • Get rid of mosquito [A.aegypti] breeding sites by emptying standing water from flower pots, buckets and barrels. If water storage is mandatory, a tight-fitting lid or thin layer of oil may prevent egg laying or hating.
  • Additionally, a person with chikungunya fever or dengue should limit their exposure to mosquito bites in order to avoid further spreading the infection. The person should stay indoors or under a mosquito net.
 
Last Updated on 15-01-2007

How to cite this url
Comped 2006 - Conference Abstracts. Pediatric Oncall [serial online] 2007 [cited 15 January 2007(Supplement 1)];4. Available from:
http://www.pediatriconcall.com/fordoctor/Conference_abstracts/
comped/Chikun.asp
 
 
 
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us